CAS: 2012536-16-0
Marca | Datos del producto | Pureza | Rango de precios | Entrega estimada |
---|---|---|---|---|
(2S,3R)-3-Hydroxy-2-((R)-5-isobutyryl-1-oxo-2,5-diazaspiro(3.4)octan-2-yl)butanamide REF: 3D-MFD53616CAS: 2012536-16-0 | Min. 95% | A consultar | Mar 21 Ene 25 | |
NYX-2925 REF: TM-T73359CAS: 2012536-16-0 | - - - | 2.070,00 €~3.647,00 € | Mar 11 Mar 25 |
(2S,3R)-3-Hydroxy-2-((R)-5-isobutyryl-1-oxo-2,5-diazaspiro(3.4)octan-2-yl)butanamide
CAS:2012536-16-0
This is a research tool for the study of ion channels. It is an activator …
Fórmula:
C14H23N3O4
Pureza:
Min. 95%
Peso molecular:
297.35 g/mol
Ref: 3D-MFD53616
1mg | A consultar | ||
5mg | A consultar | ||
10mg | A consultar | ||
25mg | A consultar | ||
50mg | A consultar |
Entrega estimada en Estados Unidos, el Martes 21 de Enero de 2025
NYX-2925
CAS:2012536-16-0
NYX-2925, an oral NMDAR modulator, enhances Src in mPFC. No CAMKII impact or addictive/sedative effects. …
Fórmula:
C14H23N3O4
Forma y color:
Liquid
Peso molecular:
297.35
Ref: TM-T73359
25mg | 2.070,00 € | ||
50mg | 2.717,00 € | ||
100mg | 3.647,00 € |
Entrega estimada en Estados Unidos, el Martes 11 de Marzo de 2025